Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
YMAB

Y-mAbs Therapeutics

$32.91

-0.88 (-2.60%)

16:05
12/05/19
12/05
16:05
12/05/19
16:05
Hot Stocks
Y-mAbs and EMA reach pact on pediatric investigation plan for omburtamab »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
YMAB

Y-mAbs Therapeutics

$32.68

0.16 (0.49%)

09:01
11/29/19
11/29
09:01
11/29/19
09:01
Hot Stocks
Y-mAbs Therapeutics initiates rolling submission of BLA for naxitamab »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YMAB

Y-mAbs Therapeutics

$28.51

-0.03 (-0.11%)

07:25
11/20/19
11/20
07:25
11/20/19
07:25
Initiation
Y-mAbs Therapeutics initiated at Guggenheim »

Guggenheim starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YMAB

Y-mAbs Therapeutics

$28.51

-0.03 (-0.11%)

16:26
11/19/19
11/19
16:26
11/19/19
16:26
Initiation
Y-mAbs Therapeutics initiated at Guggenheim »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YMAB

Y-mAbs Therapeutics

$28.01

-0.67 (-2.34%)

09:05
11/15/19
11/15
09:05
11/15/19
09:05
Hot Stocks
Y-mAbs Therapeutics announces clinical update on omburtamab in DSRCT »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YMAB

Y-mAbs Therapeutics

$28.83

0.26 (0.91%)

16:03
11/13/19
11/13
16:03
11/13/19
16:03
Earnings
Y-mAbs Therapeutics reports Q3 EPS (70c), consensus (55c) »

The company had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

Over a month ago
YMAB

Y-mAbs Therapeutics

$31.94

0.005 (0.02%)

21:59
10/29/19
10/29
21:59
10/29/19
21:59
Syndicate
Y-mAbs Therapeutics 4.465M share Spot Secondary priced at $28.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

YMAB

Y-mAbs Therapeutics

$32.00

0.07 (0.22%)

16:41
10/29/19
10/29
16:41
10/29/19
16:41
Syndicate
Y-mAbs Therapeutics announces $125M common stock offering »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YMAB

Y-mAbs Therapeutics

$30.60

0.605 (2.02%)

09:08
10/28/19
10/28
09:08
10/28/19
09:08
Hot Stocks
Y-mAbs Therapeutics announces clinical update on omburtamab »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YMAB

Y-mAbs Therapeutics

$30.00

1.855 (6.59%)

09:22
10/25/19
10/25
09:22
10/25/19
09:22
Hot Stocks
Y-mAbs Therapeutics announces clinical update on naxitamab »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.